Completed · Belgium · Pharma and biotech
Arcturus Therapeutics acquires myNEO.
Arcturus Therapeutics, based in San Diego, California, completed on 15 October 2026 its acquisition of myNEO, an AI-driven drug discovery company in Ghent, Belgium, agreed on 23 September, through its subsidiary Arcturus Therapeutics Europe B.V. At closing it paid about USD 5.0 million in cash and issued 361,355 shares, with further milestone and collaboration payments capped at USD 20.0 million in total. The deal completed on 15 October 2026.
Signing 23 September 2026 · Day 100 on 23 January 2027
- Buyer
- Arcturus Therapeutics Holdings Inc. ·San Diego, United States
- Target
- myNEO Therapeutics ·Ghent, Belgium
- Type
- Acquisition
- Announced
- 23 September 2026
- Signed
- 23 September 2026
- Completed
- 15 October 2026
- Value
- Not disclosed
- People
- Not stated in the release
- Last checked
- 6 November 2026
The people side in Belgium
- Where the deal needs EU merger clearance, the buyer may not implement it before clearance. EU Merger Regulation (Council Regulation (EC) No 139/2004), article 7
- In an asset deal, staff move on their existing terms, and the transfer alone is no ground for dismissal. Acquired Rights Directive (Council Directive 2001/23/EC), articles 3 and 4
- In an asset or business transfer, seller and buyer each inform their staff representatives in good time of the date, reasons, implications and planned measures, and consult on those measures. Acquired Rights Directive (Council Directive 2001/23/EC), article 7
- Depending on the country, undertakings with 50 or more employees, or establishments with 20 or more, inform and consult employee representatives on decisions likely to change work organisation or contractual relations substantially. Information and Consultation Directive (Directive 2002/14/EC), articles 3 and 4
- Arcturus Therapeutics press release (Exhibit 99.2 to Form 8-K), 23 September 2026 (primary source)
- Arcturus Therapeutics Form 10-Q for the quarter ended 30 September 2026 (note on subsequent events), filed 5 November 2026
- Arcturus Therapeutics third-quarter 2026 press release (Exhibit 99.1 to Form 8-K), 5 November 2026
Related deals
- 6 Nov
Midas Atlantic Partnersto
Sylvamo Europe (Sylvamo's European operations)deal page: Midas Atlantic Partners to acquire Sylvamo's Europe businessAnnounced
not statedSigningDay 100 - 5 Nov
ANI Pharmaceuticals, Inc.to
Egetis Therapeutics AB (publ)deal page: ANI Pharmaceuticals to acquire Egetis TherapeuticsAnnounced
not statedSigningDay 100 - 30 Oct
Terex Corporationto
Keestrack NVdeal page: Terex agrees to acquire KeestrackSigned
not statedSigningDay 100 - 21 Sep
Adlib Softwareto
Paperboxdeal page: Adlib agrees to acquire PaperboxSigned
not statedSigningDay 100